SenzaGen AB (FRA:26S) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:26S SenzaGen AB FRA:26S
72 GF Score
Price €0.47
GF Value €0.57
! 5 Warning Signs
View Full Analysis

What is SenzaGen AB Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:26S
72GF Score
SenzaGen AB FRA:26S
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SenzaGen AB (FRA:26S) Overvalued in 2026?

Based on GuruFocus' analysis, SenzaGen AB stock appears to be undervalued. The current stock price of €0.47 is trading 17.2% below its estimated GF Value™ of €0.57.

Key valuation signals for FRA:26S:

  • Short Ratio:
  • GF Value™: €0.57 vs. price of €0.47 (17.2% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the FRA:26S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SenzaGen AB Business Description

Other Exchanges SENZA:Sweden
Address Scheelevagen 8, Medicon Village, Building 401, Lund, SWE, 223 63
SenzaGen AB markets, sells, and performs in vitro testing using its Genomic Allergen Rapid Detection (GARD) platform through its laboratory and a network of contract research organizations. The company provides animal-free testing solutions for chemical compounds used in industries such as cosmetics, chemicals, pharmaceuticals, medical devices, and food and nutrition. Geographically, it operates in the Americas, EMEA, and APAC, with the majority of revenue from EMEA.
72GF Score

Get the complete analysis for FRA:26S

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.47
Price
€0.57
GF Value